— Know what they know.
Not Investment Advice

GNFTF OTC

Genfit S.a.
1W: +0.0% 1M: +0.0% 3M: +46.5% YTD: +162.5% 1Y: +323.4% 3Y: -1.9% 5Y: -52.4%
$15.75
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 49 · $789.0M mcap · 41M float · 0.0001% daily turnover · Short 93% of daily vol

Balance Sheet Trends

Total Assets
$151M -12.9% ▼
5Y CAGR: -13.3%
Total Liabilities
$82M -22.4% ▼
5Y CAGR: -18.3%
Shareholders Equity
$69M +1.9% ▲
5Y CAGR: -3.8%
Cash & Investments
$82M +5.1% ▲
5Y CAGR: -21.6%
Total Debt
$62M -11.5% ▼
5Y CAGR: -19.5%
Net Debt
-$20M -158.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$171M$259M$136M$78M$82M
Short-Term Investments$0$0$5M$0$0
Cash & ST Investments$171M$259M$141M$78M$82M
Net Receivables$12M$7M$16M$33M$8M
Inventory$4K$4K$4K$4K$4K
Other Current Assets$0$0$0$0$1K
Total Current Assets$185M$268M$158M$113M$93M
Property, Plant & Equip.$12M$9M$8M$8M$8M
Goodwill & Intangibles$791K$174K$44M$49M$48M
Long-Term Investments$1M$4M$5M$3M$2M
Other Non-Current Assets-$12M$3K-$56M$1M$1M
Total Non-Current Assets$14M$14M$57M$61M$59M
Total Assets$199M$282M$216M$174M$151M
— Liabilities —
Accounts Payable$20M$12M$9M$10M$18M
Short-Term Debt$2M$1M$4M$7M$55M
Deferred Revenue$124K$14M$14M$12M$0
Other Current Liabilities$1M$313K$61K$40K$39K
Total Current Liabilities$31M$63M$39M$38M$75M
Long-Term Debt$173M$66M$65M$57M$2M
Other Non-Current Liab.$2M$1M$1M$978K$1M
Total Non-Current Liabilities$184M$100M$82M$67M$7M
Total Liabilities$215M$163M$121M$106M$82M
— Equity —
Common Stock$10M$12M$12M$12M$12M
Retained Earnings-$405M-$338M-$361M-$390M-$391M
Accumulated OCI-$92K$22K-$1M$996K$347K
Total Stockholders Equity-$16M$119M$95M$68M$69M
Total Liabilities & Equity$199M$282M$216M$174M$151M
— Key Metrics —
Total Debt$186M$74M$75M$70M$62M
Net Debt$15M-$185M-$61M-$8M-$20M
Total Investments$1M$4M$9M$3M$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms